NxStage Medical, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 84   

Articles published

NXTM 17.59 +0.01 (0.06%)
price chart
NxStage Medical (NXTM) Upgraded From Sell to Hold
"We rate NXSTAGE MEDICAL INC (NXTM) a HOLD. The primary factors that have impacted our rating are mixed - some indicating strength, some showing weaknesses, with little evidence to justify the expectation of either a positive or negative performance ...
NxStage Medical Lifted to "Hold" at TheStreet (NXTM)  WKRB News
Insider Selling: Joseph E. Turk, Jr. Sells 3350 Shares of NxStage Medical ...  sleekmoney
Related articles »  
Why NxStage Medical Inc. Stock Surged Higher
Why it's happening: For the quarter, NxStage Medical reported a 13% increase in revenue to a record $75.3 million, which happened to be higher than the prior guidance issued by the company of $71 million-$72.5 million issued during its second-quarter ...
NxStage Announces Fourth Quarter 2014 Investor Conference Schedule  PR Newswire (press release)
NxStage Medical Inc.: NxStage Reports Record Third Quarter 2014 Financial ...  The Wall Street Transcript
Related articles »  
Update: NxStage Medical Q3 2014 Earnings (NXTM)
NxStage Medical's (NASDAQ:NXTM) third-quarter 2014 revenue grew 13% to a record $75.3 million, compared to $66.9 million in the year-ago period.
NxStage Launches New Streamline Express Dialyzer With Pre-attached Blood ...  PR Newswire (press release)
Insider Selling: Joseph E. Turk, Jr. Sells 29560 Shares of NxStage Medical ...  WKRB News
Related articles »  
NxStage Medical Unveils Streamline Express Dialyzer
Medical device company, NxStage Medical Inc. (NXTM), recently launched Streamline Express, a gamma sterilized dialyzer for the in-center hemodialysis market.
NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog  Nasdaq
Related articles »  
Why NxStage Medical Inc. Shares Slumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Related articles »  
NxStage Medical Rating Increased to Hold at TheStreet (NXTM)
In other NxStage Medical news, SVP Winifred L. Swan sold 17,167 shares of the company's stock on the open market in a transaction that occurred on Friday, November 14th.
NxStage Medical President Joseph E. Turk, Jr. Sells 3350 Shares (NXTM)
NxStage Medical (NASDAQ:NXTM) last announced its earnings results on Thursday, November 6th. The company reported ($0.11) earnings per share for the quarter, beating the analysts' consensus estimate of ($0.13) by $0.02.
Company Disclosure on Insider Transaction: Zep Inc , Nxstage Medical  Fico News Media
Related articles »  
NxStage Medical, Inc. (NXTM) news: NxStage Medical's CEO Discusses Q4 ...
Good day, ladies and gentlemen, and welcome to the NxStage Medical's Fourth Quarter Fiscal 2013 Financial Results Conference Call.
Related articles »  
Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using ...
Investors considering a purchase of NxStage Medical Inc (Symbol: NXTM) stock, but cautious about paying the going market price of $13.65/share, might benefit from considering selling puts among the alternative strategies at their disposal.
Related articles »  
News Roundup- Boston Scientific Corporation (NYSE:BSX), NxStage Medical ...
NxStage Medical, Inc. (NASDAQ:NXTM) currently posted third quarter revenue that surpasses the top end of its leadership range.
Related articles »